Cooperating for better care.

News & Views

Too suspicious about drugmaker-doctor links?

Share this:


Lisa Rosenbaum, M.D., writing in The New England Journal of Medicine, asks, in reference to pharmaceutical-industry and physician relations, and especially regarding the recommendation that many more people take statins:

“So why the rush to conclude that the guidelines were part of an industry plot? Have stories about industry greed so permeated our collective consciousness that we have forgotten that industry and physicians often share a mission — to fight disease?”

Contact Info

(617) 230-4965

Wellesley, Mass